SEC Info - Dupont E I De Nemours & Co - ‘10-Q’ for 9/30/16

SEC Info℠

Home

Help

Please Sign In

Dupont E I De Nemours & Co – ‘10-Q’ for 9/30/16 – ‘EX-101.SCH’

On: Tuesday, 10/25/16, at 1:40pm ET · For: 9/30/16 · Accession #: 30554-16-156 · File #: 1-00815

  As Of               Filer                 Filing    For·On·As Docs:Size

10/25/16  Dupont E I De Nemours & Co        10-Q        9/30/16   84:10M

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    704K 
 2: EX-12       Statement re: Computation of Ratios                 HTML     32K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
13: R1          Document and Entity Information                     HTML     43K 
14: R2          Consolidated Income Statements                      HTML     92K 
15: R3          Consolidated Statements of Comprehensive Income     HTML     90K 
16: R4          Condensed Consolidated Balance Sheets               HTML    122K 
17: R5          Condensed Consolidated Balance Sheets               HTML     36K 
                (Parenthetical)                                                  
18: R6          Condensed Consolidated Statements of Cash Flows     HTML    109K 
19: R7          Summary of Significant Accounting Policies          HTML     41K 
20: R8          Proposed Merger with Dow Chemical                   HTML     32K 
21: R9          Divestitures and Other Transactions                 HTML     77K 
22: R10         Employee Separation / Asset Related Charges, Net    HTML     83K 
23: R11         Other (Loss) Income, Net                            HTML     83K 
24: R12         Provision for Income Taxes                          HTML     29K 
25: R13         Earnings Per Share of Common Stock                  HTML     68K 
26: R14         Inventories                                         HTML     36K 
27: R15         Other Intangible Assets                             HTML     81K 
28: R16         Short-Term and Long-Term Borrowings                 HTML     33K 
29: R17         Commitments and Contingent Liabilities              HTML     81K 
30: R18         Stockholders' Equity                                HTML    269K 
31: R19         Financial Instruments                               HTML    195K 
32: R20         Long-Term Employee Benefits                         HTML     87K 
33: R21         Segment Information                                 HTML    158K 
34: R22         Summary of Significant Accounting Policies Summary  HTML     41K 
                of Significant Accounting Policies (Policies)                    
35: R23         Divestitures and Other Transactions Divestitures    HTML     67K 
                and Other Transactions (Tables)                                  
36: R24         Employee Separation / Asset Related Charges, Net    HTML     74K 
                (Tables)                                                         
37: R25         Other (Loss) Income, Net (Tables)                   HTML     84K 
38: R26         Earnings Per Share of Common Stock (Tables)         HTML     68K 
39: R27         Inventories (Tables)                                HTML     36K 
40: R28         Other Intangible Assets (Tables)                    HTML     78K 
41: R29         Commitments and Contingent Liabilities (Tables)     HTML     52K 
42: R30         Stockholders' Equity (Tables)                       HTML    257K 
43: R31         Financial Instruments (Tables)                      HTML    181K 
44: R32         Long-Term Employee Benefits (Tables)                HTML     82K 
45: R33         Segment Information (Tables)                        HTML    157K 
46: R34         Summary of Significant Accounting Policies Recent   HTML     32K 
                Accounting Pronouncements (Details)                              
47: R35         Proposed Merger with Dow Chemical (Narrative)       HTML     26K 
                (Details)                                                        
48: R36         Divestitures and Other Transactions (Narrative)     HTML    103K 
                (Details)                                                        
49: R37         Divestitures and Other Transactions (Schedule of    HTML     59K 
                results of operations from discontinued                          
                operations) (Details)                                            
50: R38         Divestitures and Other Transactions (Schedule of    HTML     32K 
                cash flow information of discontinued operations)                
                (Details)                                                        
51: R39         Employee Separation / Asset Related Charges, Net    HTML     35K 
                (La Porte) (Narrative) (Details)                                 
52: R40         Employee Separation / Asset Related Charges, Net    HTML     76K 
                (2016 Restructuring Program schedule )(Details)                  
53: R41         Employee Separation / Asset Related Charges, Net    HTML     57K 
                (2014 Restructuring Program schedule) (Details)                  
54: R42         Employee Separation / Asset Related Charges, Net    HTML     35K 
                (Narrative) (Details)                                            
55: R43         Employee Separation / Asset Related Charges, Net    HTML     34K 
                (Asset Impairment) (Narrative) (Details)                         
56: R44         Other (Loss) Income, Net (Schedule of Other         HTML     55K 
                Income) (Details)                                                
57: R45         Other (Loss) Income, Net (Schedule of Foreign       HTML     39K 
                Exchange Gain (Loss)) (Details)                                  
58: R46         Provision for Income Taxes (Details)                HTML     29K 
59: R47         Earnings Per Share of Common Stock (Earnings Per    HTML     49K 
                Share of Common Stock Reconciliation) (Details)                  
60: R48         Earnings Per Share of Common Stock (Schedule of     HTML     30K 
                Average Number of Antidilutive Stock Options)                    
                (Details)                                                        
61: R49         Inventories (Details)                               HTML     37K 
62: R50         Other Intangible Assets (Schedule of Other          HTML     71K 
                Intangible Assets) (Details)                                     
63: R51         Other Intangible Assets (Narrative) (Details)       HTML     45K 
64: R52         Short-Term and Long-Term Borrowings (Details)       HTML     73K 
65: R53         Commitments and Contingent Liabilities              HTML     60K 
                (Guarantees) (Details)                                           
66: R54         Commitments and Contingent Liabilities              HTML     97K 
                (Litigation) (Narrative) (Details)                               
67: R55         Commitments and Contingent Liabilities              HTML     38K 
                (Environmental) (Narrative) (Details)                            
68: R56         Stockholders' Equity (Share Repurchase Program)     HTML     54K 
                (Narrative) (Details)                                            
69: R57         Stockholders' Equity (Noncontrolling Interest)      HTML     30K 
                (Narrative) (Details)                                            
70: R58         Stockholders' Equity (Schedule of Other             HTML    197K 
                Comprehensive Income) (Details)                                  
71: R59         Stockholder's Equity (Schedule of Accumulated       HTML     81K 
                Other Comprehensive Loss) (Details)                              
72: R60         Financial Instruments (Schedule of Cash, Cash       HTML     65K 
                Equivalents and Marketable Securities) (Details)                 
73: R61         Financial Instruments (Debt) (Narrative) (Details)  HTML     26K 
74: R62         Financial Instruments (Notional Amounts of          HTML     34K 
                Derivatives) (Details)                                           
75: R63         Financial Instruments (Effect of Cash Flows Hedges  HTML     37K 
                on Accumulated Other Comprehensive Income (Loss))                
                (Details)                                                        
76: R64         Financial Instruments (Schedule of the Fair Value   HTML     52K 
                of Derivative Instruments) (Details)                             
77: R65         Financial Instruments (Effect of Derivative         HTML     67K 
                Instruments) (Details)                                           
78: R66         Long-Term Employee Benefits (Schedules of Net       HTML     80K 
                Periodic Benefit Cost) (Details)                                 
79: R67         Segment Information (Schedule of Segment            HTML     51K 
                Information) (Details)                                           
80: R68         Segment Information (Reconciliation to              HTML     77K 
                Consolidated Income Statements) (Details)                        
81: R69         Segment Information (Significant Pre-tax (charges)  HTML    128K 
                benefits not included in Segment Operating                       
                Earnings) (Details)                                              
83: XML         IDEA XML File -- Filing Summary                      XML    156K 
82: EXCEL       IDEA Workbook of Financial Reports                  XLSX    103K 
 7: EX-101.INS  XBRL Instance -- dd-20160930                         XML   3.95M 
 9: EX-101.CAL  XBRL Calculations -- dd-20160930_cal                 XML    261K 
10: EX-101.DEF  XBRL Definitions -- dd-20160930_def                  XML   1.10M 
11: EX-101.LAB  XBRL Labels -- dd-20160930_lab                       XML   1.88M 
12: EX-101.PRE  XBRL Presentations -- dd-20160930_pre                XML   1.20M 
 8: EX-101.SCH  XBRL Schema -- dd-20160930                           XSD    219K 
84: ZIP         XBRL Zipped Folder -- 0000030554-16-000156-xbrl      Zip    322K

‘EX-101.SCH’ — XBRL Schema — dd-20160930

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dupont.com/20160930" xmlns:dd="http://www.dupont.com/20160930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">

<xsd:import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-roles/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-roles-2016-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>

<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/currency/2016-01-31" schemaLocation="http://xbrl.sec.gov/currency/2016/currency-2016-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/exch/2016-01-31" schemaLocation="http://xbrl.sec.gov/exch/2016/exch-2016-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>

<xsd:annotation>

<xsd:appinfo>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dd-20160930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dd-20160930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dd-20160930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dd-20160930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>

<link:roleType id="CommitmentsAndContingentLiabilities" roleURI="http://www.dupont.com/role/CommitmentsAndContingentLiabilities">

<link:definition> 2118100 - Disclosure - Commitments and Contingent Liabilities </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>